ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Grants Funding; NCI Restores Paylines To Last Year’s Levels

July 4, 1997

NCI Cooperative Group Clinical Trials Approved

September 24, 2010

ODAC Votes 10-0 In Favor Of Avastin For Recurrent Glioblastoma Multiforme

April 3, 2009

Chi Van Dang Named Director of University Of Pennsylvania Abramson Cancer Center

July 15, 2011

Major Decisions On How NCI Will Spend Extra Money Won’t Be Made for Three-Four Months

November 4, 1983

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994